Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00468858Phase 2Completed
A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children
Dengue FeverDengue Hemorrhagic FeverDengue Shock Syndrome
Principalinvestigator

Research Network

Collaboration Network

12 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Private Practice, PR

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Alberto Santiago-Cornier, MD

Department of Molecular Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

DengueSevere DengueDengue Shock Syndrome

Worked with same sponsors:

GlaxoSmithKlineU.S. Army Medical Research and Development Command
Collaborated on 1 trial
Similarity Score34%

Jose Tavarez-Valle, MD

Private Practice, PR

Moderately Similar
1 trials

Shared therapeutic areas:

DengueSevere DengueDengue Shock Syndrome

Worked with same sponsors:

GlaxoSmithKlineU.S. Army Medical Research and Development Command
Collaborated on 1 trial
Similarity Score34%

Clemente Diaz-Perez, MD

University of PR

Moderately Similar
1 trials

Shared therapeutic areas:

DengueSevere DengueDengue Shock Syndrome

Worked with same sponsors:

GlaxoSmithKlineU.S. Army Medical Research and Development Command
Collaborated on 1 trial
Similarity Score34%

Evelyn Matta-Fontanet, MD

Caparra Internal Medicine Research Center

Moderately Similar
1 trials

Shared therapeutic areas:

DengueSevere DengueDengue Shock Syndrome

Worked with same sponsors:

GlaxoSmithKlineU.S. Army Medical Research and Development Command
Collaborated on 1 trial
Similarity Score34%

Miguel Sosa-Padilla, MD

Private Practice PR

Moderately Similar
1 trials

Shared therapeutic areas:

DengueSevere DengueDengue Shock Syndrome

Worked with same sponsors:

GlaxoSmithKlineU.S. Army Medical Research and Development Command
Collaborated on 1 trial
Similarity Score34%

Jose Rodriguez-Santana, MD

Centro de Neumologia pediatrica

Moderately Similar
1 trials

Shared therapeutic areas:

DengueSevere DengueDengue Shock Syndrome

Worked with same sponsors:

GlaxoSmithKlineU.S. Army Medical Research and Development Command
Collaborated on 1 trial
Similarity Score34%

Ines O. Esquilin-Rivera, MD

University of PR

Moderately Similar
1 trials

Shared therapeutic areas:

DengueSevere DengueDengue Shock Syndrome

Worked with same sponsors:

GlaxoSmithKlineU.S. Army Medical Research and Development Command
Collaborated on 1 trial
Similarity Score34%

Domingo Chardon-Feliciano, MD

Ponce School of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

DengueSevere DengueDengue Shock Syndrome

Worked with same sponsors:

GlaxoSmithKlineU.S. Army Medical Research and Development Command
Collaborated on 1 trial
Similarity Score34%

Jorge Bertran-Pasarell, MD

Dept Medicina Interna Seccion Enfermedades Infecciosas

Moderately Similar
1 trials

Shared therapeutic areas:

DengueSevere DengueDengue Shock Syndrome

Worked with same sponsors:

GlaxoSmithKlineU.S. Army Medical Research and Development Command
Collaborated on 1 trial
Similarity Score34%

Anna Quintero, MD

San Juan Batista Medical School

Moderately Similar
1 trials

Shared therapeutic areas:

DengueSevere DengueDengue Shock Syndrome

Worked with same sponsors:

GlaxoSmithKlineU.S. Army Medical Research and Development Command
Collaborated on 1 trial
Similarity Score34%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00468858Phase 2PrincipalInvestigator

A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children

Dengue FeverDengue Hemorrhagic FeverDengue Shock Syndrome
Completed

All 1 trials loaded